Pouyan Ebrahimi

Dr. Pouyan Ebrahimi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2024 in eClinicalMedicine
Verified
Journal Article
Open access
APAli Tavakoli Pirzaman
Ali Tavakoli Pirzaman
MSMahdi Sepidarkish
Mahdi Sepidarkish
FAFaezeh Alizadeh
Faezeh Alizadeh
SASarah Al-Obidy
Sarah Al-Obidy
PEPouyan Ebrahimi
Pouyan Ebrahimi
ARAli Rostami
Ali Rostami
Schistosoma mansoni infection poses a substantial public health challenge globally, and the World Health Organization (WHO) aims for the elimination of schistosomiasis by 2030. This study aimed to assess the current prevalence of human S. mansoni infection in endemic regions worldwide between 2010 and 2024. We conducted a comprehensive search in PubMed/Medline and Scopus databases as well as other public sources from 1 January 2010 to 15 July 2024. Population-based studies reporting the prevalence of S. mansoni infection were eligible. We undertook a random-effects meta-analysis to estimate pooled prevalences with 95% confidence intervals (CIs) in WHO-defined regions and assessed potential risk factors associated with S. mansoni infection. The protocol for this study was registered on PROSPERO (CRD42023438455). We identified a total of 542 eligible studies involving 1,163,866 individuals who had been tested for S. mansoni infection in 38 countries. The overall, pooled global prevalence of S. mansoni infection in endemic region was 14.8% (95% CI, 13.5%–16.1%). The pooled prevalences (95% CI) in specific regions were: 15.3% (13.9–16.8%) in sub-Saharan Africa, 12.4% (8.9–16.4%) in South America and 9.5% (5.4–14.6%) in the Eastern Mediterranean region. There was a 52.6% decrease in prevalence of S. mansoni infection and a 37% decrease in high-intensity infection for studies conducted between 2010 and 2014 compared to those conducted between 2020 and 2023. The present analysis revealed that factors including male gender, bathing or swimming in natural water bodies, crossing rivers or lakes, and engaging in water irrigation activities such as fishing, working in rice paddies or maintaining irrigation canals were significantly associated with S. mansoni infection. The findings of this investigation revealed that, despite a decline in prevalence and high-intensity infection, 7–12% of people in endemic regions, notably in sub-Saharan Africa, remained affected by schistosomiasis mansoni between 2020 and 2024. This study provides data of relevance to policymakers to support efforts to eliminate this disease. This study received no funding.

26 December 2025 in Annals of Medicine
Verified
Journal Article
Open access
ASAmin Esmaeilnia Shirvani
Amin Esmaeilnia Shirvani
KPKimia Pakdaman
Kimia Pakdaman
ZMZahra Maleki
Zahra Maleki
SSSoroush Soraneh
Soroush Soraneh
FCFatemeh Rezaei Chegini
Fatemeh Rezaei Chegini
PEPouyan Ebrahimi
Pouyan Ebrahimi
Haemorrhoidal disease (HD) is one of the most common anorectal disorders globally, significantly impacting individuals' quality of life and productivity. Despite its importance, global prevalence remains unclear due to limited population-specific studies. This study aimed to systematically assess the global prevalence of HD through a systematic review and meta-analysis. We conducted a systematic review and meta-analysis by searching PubMed, Scopus, Embase, Web of Science, and Google Scholar up to March 31, 2025, without language restrictions. Studies reporting prevalence of haemorrhoids in general, clinical, or high-risk populations were included. Exclusion criteria comprised studies lacking total sample size, focusing on other anorectal conditions, or using duplicate or insufficient data. Four independent reviewers extracted and appraised study quality using the Joanna Briggs Institute tool. The primary outcome was pooled point prevalence of HD, analyzed using a random-effects model with 95% confidence intervals (CIs). The study was registered in PROSPERO (CRD420251045600). From 6,312 records, 150 studies (210 datasets) comprising 8,960,338 individuals were included. The global pooled point prevalence was 25.92% (95% CI: 22.62-29.22). Lifetime prevalence was 27.19% (95% CI: 14.77-39.60), and one-year prevalence was 21.65% (95% CI: 14.33-28.97). Prevalence was higher in women (27.33%, 95% CI: 21.84-32.82) than in men, and highest in the African region 28.07% (95% CI: 15.34-40.79). Invasive diagnostic methods (28.05%, 95% CI: 23.86-32.26) yielded higher prevalence estimates than non-invasive methods. Also, factors showing associations with HD in unadjusted analyses include older age, obesity, pregnancy, diabetes, family history, constipation, and hypertension. HD remains a prevalent condition globally, with minor variation across regions. The burden is consistent regardless of socioeconomic context. Diagnostic method and population characteristics influence prevalence estimates. These findings underscore the importance of targeted prevention and early intervention strategies, especially for at-risk groups.

22 January 2025 in Cancer Reports
Verified
Journal Article
Open access
PEPouyan Ebrahimi
Pouyan Ebrahimi
SKSara Khaleghi
Sara Khaleghi
MVMohebat Vali
Mohebat Vali
SDSahar Delavari
Sahar Delavari
SKSoraya Khafri
Soraya Khafri
HNHossein‐Ali Nikbakht
Hossein‐Ali Nikbakht
Background: Cancer is a major cause of mortality. Timely information about cancer mortality trends is essential for prioritizing health programs.Aims: This study aims to use a Joint point regression model to predict the mortality rates of the top 10 common cancers in Babol City.Methods: This cross‐sectional study considered all registered cancer‐related deaths from 2013 to 2021 in the Babol University of Medical Sciences' death registration and classification system. Crude and age‐standardized rates and cancer trends were calculated and predicted for the next 5 years, overall and by type of cancer and gender.Results: Over these 9years, 2417 deaths from the 10 common cancers were recorded. We observed an increase in mortality rates with a slope of 12.05% from 2013 to 2016, and a gentler slope of 3.2% from 2016 to 2021. Cancer mortality rates are predicted to increase by 6.43% in the next 5 years without intervention. Detailed analysis indicates that breast cancer will have the highest mortality rate during 2022–2026, rising by 13.6% annually. Predictions based on gender indicate that, breast cancer mortality will increase by 13.6% annually for women. Also, stomach cancer mortality rates will increase by 0.15% in men annually.Conclusion: Cancer mortality in Babol remains a significant public health issue with an increasing trend. Nevertheless, these rising mortality rates require urgent interventions, including cancer prevention programs, increased access to medical services, and improved quality of life.

1 March 2023 in Human & Experimental Toxicology
Verified
Journal Article
Open access
APAli Tavakoli Pirzaman
Ali Tavakoli Pirzaman
PEPouyan Ebrahimi
Pouyan Ebrahimi
SDShahrbanoo Doostmohamadian
Shahrbanoo Doostmohamadian
BKBardia Karim
Bardia Karim
DADarya Almasi
Darya Almasi
SKSohrab Kazemi
Sohrab Kazemi
The chemotherapeutic drug 5-fluorouracil (5FU) is frequently used to treat a wide range of solid malignant tumors, such as colorectal, pancreatic, gastric, breast, and head and neck cancers. Its antitumoral effects are achieved by interfering with the synthesis of RNA and DNA and by inhibiting thymidylate synthase in both malignant and non-malignant cells. Therefore, it can be responsible for severe toxicities in crucial body organs, including heart, liver, kidney, and reproductive system. Given the fact that 5FU-induced reproductive toxicity may limit the clinical application of this drug, in this study, we aimed to discuss the main locations and mechanisms of the 5FU-induced reproductive toxicity. Initially, we discussed the impact of 5FU on the male reproductive system, which leads to damage of the seminiferous epithelial cells and the development of vacuoles in Sertoli cells. Although no noticeable changes occur at the histopathological level, there is a decrease in the weight of the prostate. Additionally, 5FU causes significant abnormalities in spermatogenesis, including germ cell shedding, spermatid halo formation, polynucleated giant cells, and decreased sperm count. Finally, in females, 5FU-induced reproductive toxicity is characterized by the presence of atretic secondary and antral follicles with reduced numbers of growing follicles, ovarian weight, and maturity impairment.

1 May 2014 in Journal of Applied Geophysics
Verified
Journal Article
Closed access
PJP. Jaiswal
P. Jaiswal
BVB. Varacchi
B. Varacchi
PEPouyan Ebrahimi
Pouyan Ebrahimi
JDJack Dvorkin
Jack Dvorkin
JPJ. Puckette
J. Puckette

19 December 2025 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
MSMalihe Nourollahpour Shiadeh
Malihe Nourollahpour Shiadeh
KPKimia Pakdaman
Kimia Pakdaman
ASAmin Esmaeilnia Shirvani
Amin Esmaeilnia Shirvani
ZHZeinab Hashemi
Zeinab Hashemi
PEPouyan Ebrahimi
Pouyan Ebrahimi
Stroke is a leading cause of death and disability worldwide, with its prevalence increasing due to risk factors such as hypertension, diabetes, and hyperli